ADMA Biologics to Present at the Oppenheimer 26th Annual Healthcare Conference
RAMSEY, N.J., Dec. 03, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain …